Headlines

MID WEB AD_Vertical left side 426 pixels (height) x 170 pixels (width).gif

GT Metabolic Solutions gains CE mark for GT Metabolic Magnet System

GT Metabolic Solutions has received CE certification (CE Mark) under the EU Medical Device Regulation (EU MDR) that enables commercialisation of the GT Metabolic Magnet System across the European Economic Area (EEA). GT Metabolic achieved successful review and certification of the GT Metabolic Magnet System for side-to-side enteroenterostomy (40mm, 50mm Magnets; throughout the small bowel) and gastroenterostomy (60mm, 70mm Magnets; stomach to small bowel), the first integrate

GT Metabolic Solutions gains CE mark for GT Metabolic Magnet System

Study strengthens the case for insurers and policymakers to support coverage and improve access to MBS

PET imaging tracks whole-body metabolic changes after surgery

Research

GT Metabolic Solutions gains CE mark for GT Metabolic Magnet System

More than half of those who stop GLP-1s restart within a year

People prescribed GLP-1 medications are more likely to start and stop than most people assume, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago. "Our study asked two questions that haven't been well answered until now: How many people with type 2 diabetes taking GLP-1 medications actually stop using them? And how many restart them?" said Dr Sainikhil Sontha, a research associate at Boston University School of Public Health in Bost

Study strengthens the case for insurers and policymakers to support coverage and improve access to MBS

Metabolic and bariatric surgery (MBS) for teens with severe obesity is cost-effective over ten years, according to an analysis from Ann & Robert H Lurie Children's Hospital of Chicago, IL. While long-term clinical benefits of weight-loss surgery for eligible teens have been well established, and it is recommended by the American Academy of Pediatrics, insurance coverage has been limited and few teens can take advantage of the surgery. This study strengthens the case for insur

Organisations publish first-ever guideline on cardiovascular-kidney-metabolic syndrome

The American Heart Association, the American College of Cardiology, the American Diabetes Association, the Obesity Association and the American Society of Nephrology, have developed the first-ever guideline aimed at preventing and managing cardiovascular-kidney-metabolic (CKM) syndrome, an interconnected set of health conditions that significantly increase the risk of multiorgan complications and adverse cardiovascular outcomes. The recommendations have been developed to help

Americans with severe obesity receive fewer surgeries despite rising need

A study led Pennington Biomedical researchers highlights growing disparities in standard surgical care access for individuals with extreme obesity and Americans with the highest levels of obesity are undergoing fewer surgical procedures overall. These procedures include common operations like knee or hip replacement, hernia surgery, and surgery of the breast, prostate and colon – operations that are frequently done to treat cancer. “Understanding and addressing these disparit

NBSR outcomes data demonstrates low mortality rate of metabolic and bariatric surgery in England

Publication of the latest data from the National Bariatric Surgical Registry (NBSR) has demonstrated that in-hospital survival from metabolic and bariatric surgery (MBS) is at least as good, if not better, than many common laparoscopic gastrointestinal procedures. Omar Khan Surgical data from metabolic and bariatric surgery (MBS) in England revealed an in-hospital mortality rate of 0.035% with three recorded in-hospital deaths from 8,454 procedures, between March 2023 and Apr

Wayne State University secures US patent for technology that detects and visualises arterial bleeding during surgeries

The United States Patent and Trademark Office (USPTO) has issued a new patent to Wayne State University and RediMinds that protects a technology that aims to detect and visualize arterial bleeding during surgeries. US Patent No. 12,635,098 B2 is titled, ‘Systems and Methods for Detecting, Localizing, Assessing and Visualizing Bleeding in a Surgical Field’ and recognises an inventive step forward in addressing intraoperative bleeding, a major complication of minimally invasive

Medtronic submits 510(k) filings to expand Hugo robotic-assisted surgery

Medtronic has announced significant milestones to unlock expanded indications for the Hugo robotic-assisted surgery (RAS) system in the US. The company has submitted 510(k) clearance for gynaecological surgery, general surgery indication including hernia repair, the LigaSure RAS Maryland instrument and for the ProGrip Advanced mesh for use in robotic-assisted ventral hernia repair. These milestones build momentum for Medtronic's Surgical business and its purposeful launch of

Researchers develop the Lily stent to treat gastric leaks

Researchers at New York University Tandon School of Engineering have developed a new stent to treat gastric leaks. Their prototype, called the Lily stent, is the first product of a design framework the researchers named Personalized Endoscopic Transmural Abscess Leak Solution (PETALS), a mathematical approach to optimizing drain shape for complex biological fluids that the team says could be applied beyond gastric leaks to other drainage challenges in the body. Overview of th

Weight loss drugs risk widening health inequalities

Weight loss drugs such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) are transforming obesity treatment, but without affordable, healthy food and appropriate support, they could widen health inequalities in the UK, according to researchers at University College London and the University of Cambridge, UK. The researchers argue that while incretin-based therapies, also known as weight loss medications, have transformed obesity treatment, their long-term benefits ma

GLP-1 linked to lower breast cancer incidence in large cohort study

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Dr Elizabeth McDonald, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing brea

PET imaging tracks whole-body metabolic changes after surgery

A novel PET imaging framework reveals that bariatric surgery impacts not only body weight, but also the metabolic function of multiple organs. These PET-derived insights into organ-level responses to surgery could support more precise treatment monitoring and personalized metabolic care, according to a study, ‘Evaluation of organic metabolic profiling alternation assessed by [18F]FDG PET/CT in obese patients before and after bariatric surgery’, presented at the Society of Nu